We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

CORMAY

Cormay develops and manufactures diagnostic reagents and laboratory equipment, including hematology analyzers and cli... read more Featured Products: More products

Download Mobile App





Cormay Diagnostics Introduces True 5+ DIFF Multi-Patented Hematology Solution at MEDICA 2022

By LabMedica International staff writers
Posted on 16 Nov 2022
Print article
Cormay at MEDICA 2022 (Photo courtesy of Cormay)
Cormay at MEDICA 2022 (Photo courtesy of Cormay)

Cormay Diagnostics (Warsaw, Poland) is participating in this year’s edition of MEDICA, where the company is presenting its range of high quality diagnostic reagents and advanced laboratory analyzers.

At MEDICA 2022, Cormay is showcasing the MYTHIC 70, a true 5+DIFF hematology analyzer that delivers 29 parameters in less than 60 seconds. Its superior technology ensures reliability and multi-patented solution with unmatchable cost savings. It features walk away function and allows loading of 50 samples for improving laboratory efficiency. Alongside the MYTHIC 70, Cormay is exhibiting the MYTHIC 3CRP, a 3 DIFF hematology analyzer that offers a two-in-one solution. The MYTHIC 3CRP analyzer is designed to analyze whole blood samples, including measurement of blood cell count, hemoglobin concentration, CRP concentration and 3-part leukocytes differentiation.

In addition to its range of hematology analyzers, Cormay is also highlighting its portfolio of chemistry analyzers, including the ACCENT M320 and ACCENT S120. The ACCENT M320 and ACCENT S120 are computer-controlled, fully-automated chemistry analyzers for in-vitro diagnostic use in clinical laboratories to measure activity or concentration of clinical chemistry parameters in serum, plasma, urine and cerebrospinal fluid samples. Together with the highest quality dedicated reagent line, calibrators and controls, they provide a complete solution suitable for small to mid-size laboratories.

Among its urine analyzers being showcased by Cormay at MEDICA 2022 are the Uri-Tex and URI-TEX 300 semi-automatic urine chemistry analyzers. Designed to be used with Cormay urinalysis strips, the intelligent Uri-Tex image analyzer locates the strip and the pads, reads the color data, and based on these, determines the parameter values. Its intuitive device operation makes analysis easy and allows for fast determination of multiple chemical compounds in urine. Similarly, the Uri-Tex 300 semiautomatic urine chemistry analyzer is also designed to be used with Cormay urinalysis strips and determines the multiple parameters values in urine in less than a minute. The operator is only required to dip the strips into the samples and place them on the strips loading plate which allows for a maximum of 10 strips to be loaded at one time.

Related Links:
Cormay Diagnostics

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Researchers have found a way to spot the debilitating disease Alzheimer\'s before it develops into dementia (Photo courtesy of 123RF)

Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia

Alzheimer’s disease is well known for its slow development over many years, which typically leads to treatment interventions only after the disease has advanced to stages where it may be nearly impossible... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.